Unknown

Dataset Information

Dendritic cell vaccines containing lymphocytes produce improved immunogenicity in patients with cancer.


ABSTRACT:

Background

Dendritic cells are currently under investigation for their ability to generate anti-cancer immune responses. No consensus has been reached as to the optimal method of dendritic cell vaccine preparation and is a barrier to success in the field.

Methods

Over a course of three separate dendritic cell vaccine studies to treat cancer, we tested two different methods for preparing dendritic cells from peripheral blood mononuclear cells: adherence and antibody-selected CD14+ cells.

Results

Surprisingly, we found that patients who received dendritic cell vaccines generated by the adherence method mounted increased T cell proliferation in response to vaccination. This difference could not be accounted for by dendritic cell vaccine dose, cell surface phenotype or de

SUBMITTER: Frank MO 

PROVIDER: S-EPMC4264264 | biostudies-literature | 2014 Dec

REPOSITORIES: biostudies-literature